Elevation of Serum Transforming Growth Factor- 1 Level in Patients with Metastatic Prostate Cancer

By Kakehi Y.   Oka H.   Mitsumori K.   Itoh N.   Ogawa O.   Yoshida O.  

Urologic Oncology: Seminars and Original Investigations, Vol. 2, Iss. 5, 1996-09 ,pp. : 131-135

Elsevier

Access to resources Recommend Favorite

Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer

By Lucarelli Giuseppe   Ditonno Pasquale   Bettocchi Carlo   Spilotros Marco   Rutigliano Monica   Vavallo Antonio   Galleggiante Vanessa   Fanelli Margherita   Larocca Angela Maria Vittoria   Germinario Cinzia Annatea   Maiorano Eugenio   Selvaggi Francesco Paolo   Battaglia Michele  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 899-907

Future Medicine

Access to resources Recommend Favorite

Follistatin as potential therapeutic target in prostate cancer

By Sepporta Maria   Tumminello Francesca   Flandina Carla   Crescimanno Marilena   Giammanco Marco   Guardia Maurizio   Majo Danila   Leto Gaetano  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite

Elevated Concentrations of Serum Relaxin are Associated with Metastatic Disease in Breast Cancer Patients

By Binder C.   Simon A.  

Breast Cancer Research and Treatment, Vol. 87, Iss. 2, 2004-09 ,pp. : 157-166

Springer Publishing Company

Access to resources Recommend Favorite

Acquisition of metastatic tissue from patients with bone metastases from breast cancer

By Hilton J.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 761-765

Springer Publishing Company

Access to resources Recommend Favorite